Medical devices, healthcare technology and the business of care
510(k) clearance · K253469

Ritus Safety Fistula Cannula with Anti-Reflux Valve 15G x 30mm (1530VSMM); Ritus Safety Fistula Cannula with Anti-Reflux Valve 15G x 38mm (1538VSMM); Ritus Safety Fistula Cannula with Anti-Reflux Valve 16G x 30mm (1630VSMM); Ritus Safety Fistula Cannula with Anti-Reflux Valve 16G x 38mm (1638VSMM); Ritus Safety Fistula Cannula with Anti-Reflux Valve 17G x 30mm (1730VSMM); Ritus Safety Fistula Cannula with Anti-Reflux Valve 17G x 38mm (1738VSMM)

Mozarc Medical Us, LLC · Decision date Aug 6, 2026

FDA DECISIONK253469

What did the FDA decide?

FDA records K253469 as a 510(k) premarket notification, with a decision dated Aug 6, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Aug 6, 2026

FDA source record

Regulatory record facts

Identifier
K253469
Regulatory pathway
510(k) premarket notification
Product code
FIE
Decision code
SESE
Decision date
Aug 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Needle, Fistula.

Product code
FIE
FDA device class
2

FDA decision timeline

  1. K253469 received

    Application receipt date recorded by FDA.

  2. K253469 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Mozarc Medical Us, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Mansfield, MA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records